Advances in Omics Technologies in GBM
Glioblastoma multiforme (GBM) is one of the most lethal human cancers and poses a great challenge in the therapeutic interventions of GBM patients worldwide. Despite prominent recent advances in oncology, on an average GBM patients survive 12–15 months with conventional standard of care treatment. T...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Seri Bilgileri: | Biomedical Research Journal |
| Konular: | |
| Online Erişim: | http://www.brjnmims.org/article.asp?issn=2349-3666;year=2015;volume=2;issue=1;spage=6;epage=20;aulast=Maachani;type=0 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|